13F filer · CIK 2111120
MWG Caph Ltd
WASHINGTON, DC · filing since Q4 2025 · last filing Feb 17, 2026
Reported value
$72.4M
Positions
3
New / sold out
3 / 0
Added / reduced
0 / 0
Turnover
–
buys $72.4M · sells $0
Top-10 weight
100.0%
No 13F for Q3 2025, so every position this quarter shows as new.
Biggest buys vs Q3 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | BEAM THERAPEUTICS INC | +1,266,934 | – | +$35.1M |
| New | LYELL IMMUNOPHARMA INC | +1,008,116 | – | +$31.0M |
| New | PRIME MEDICINE INC | +1,792,210 | – | +$6.2M |
Biggest sells vs Q3 2025
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INCCOM | 1,266,934 | $35.1M | 48.53% |
| 2 | LYELL IMMUNOPHARMA INCCOM NEW | 1,008,116 | $31.0M | 42.88% |
| 3 | PRIME MEDICINE INCCOM | 1,792,210 | $6.2M | 8.59% |